Reduced-dose intravenous thrombolysis for acute intermediate high-risk pulmonary embolism: Rationale and design of the PEITHO-3 trial
Contributeurs/tricesSanchez, Olivier; Charles-Nelson, Anais; Ageno, Walter; Barco, Stefano ; Binder, Harald; Chatellier, Gilles; Duerschmied, Daniel; Empen, Klaus; Ferreira, Melanie; Girard, Philippe; Huisman, Menno V; Jiménez, David; Katsahian, Sandrine; Kozak, Matija; Lankeit, Mareike; Meneveau, Nicolas; Pruszczyk, Piotr; Petris, Antoniu; Righini, Marc Philip; Rosenkranz, Stephan; Schellong, Sebastian; Stefanovic, Branislav; Verhamme, Peter ; de Witt, Kerstin; Vicaut, Eric; Zirlik, Andreas; Konstantinides, Stavros ; Meyer, Guy; PEITHO-3 Investigators
Publié dansThrombosis and haemostasis
Date de publication2021-09-24
Date de mise en ligne2021-09-24
Résumé
Mots-clés
- Pulmonary embolism
- Intermediate–high
- Risk
- Reduced
- Dose thrombolysis
- Prognosis
- Randomized trial
Structure d'affiliation
Groupe de recherche
Financement
- KO 1939/3-1 - [Deutsche Forschnungsgemeinschaft]
- PHRCN-16-0580 - [Programme hospitalier de recherche clinique]
Citation (format ISO)
SANCHEZ, Olivier et al. Reduced-dose intravenous thrombolysis for acute intermediate high-risk pulmonary embolism: Rationale and design of the PEITHO-3 trial. In: Thrombosis and haemostasis, 2021. doi: 10.1055/a-1653-4699
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:158935
- DOI : 10.1055/a-1653-4699
- PMID : 34560806
ISSN du journal0340-6245